Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Meta-Anal. Sep 18, 2025; 13(3): 107531
Published online Sep 18, 2025. doi: 10.13105/wjma.v13.i3.107531
Published online Sep 18, 2025. doi: 10.13105/wjma.v13.i3.107531
Future of research on inflammatory bowel disease in Nigeria: Gaps and opportunities
Yusuf Musa, Department of Internal Medicine, Federal Teaching Hospital Katsina, Katsina 820101, Katsina, Nigeria
Phoebe Hodges, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom
Nasiru Altine Dankiri, Department of Internal Medicine, Usmanu Danfodiyo university teaching hospital, Sokoto 840101, Nigeria
Oluwafunmilayo Funke Adeniyi, Department of Paediatrics, College of Medicine, University of Lagos, Lagos 100253, Nigeria
Pantong Mark Davwar, Department of Medicine, Jos University Teaching Hospital, Jos 030105, Plateau State, Nigeria
Habib Tijjani Saleh, Department of Internal Medicine, Federal Teaching Hospital Katsina, Katsina 820101, Nigeria
Musa Muhammad Borodo, Department of Internal Medicine, Aminu Kano Teaching Hospital, Kano 700101, Nigeria
Musa Muhammad Borodo, Department of Internal Medicine, Bayero University, Kano 700101, Kano, Nigeria
Co-corresponding authors: Yusuf Musa and Habib Tijjani Saleh.
Author contributions: The study was conceptualized by Musa Y, Hodges P, and Borodo MM; Musa Y, Dankiri NA, Hodges P, Davwar PM, Adeniyi OF, and Saleh HT contributed to defining the intellectual content, conducting the literature search, and preparing the manuscript; Musa Y and Saleh HT have played important and indispensable roles in the manuscript as the co-corresponding authors; all authors participated in editing and reviewing the manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yusuf Musa, MD, Department of Internal Medicine, Federal Teaching Hospital Katsina, Murtala Muhammad Way, Opposite Jibia Road, Katsina 820101, Nigeria.
Received: March 26, 2025
Revised: May 9, 2025
Accepted: July 23, 2025
Published online: September 18, 2025
Processing time: 169 Days and 2.1 Hours
Revised: May 9, 2025
Accepted: July 23, 2025
Published online: September 18, 2025
Processing time: 169 Days and 2.1 Hours
Core Tip
Core Tip: To effectively tackle the increasing burden of inflammatory bowel disease (IBD) in Nigeria, a multifaceted approach is necessary. First, comprehensive epidemiological studies are vital to better understand IBD’s prevalence and risk factors. Raising public awareness through targeted education and improving healthcare professionals' knowledge with ongoing training are crucial for early detection. Enhancing healthcare infrastructure by establishing specialized IBD diagnostic and treatment centers is also essential. Finally, fostering collaboration among researchers, clinicians, policymakers, and patient advocacy groups will help advance research, streamline healthcare delivery, and improve patient outcomes.